{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:59:54Z","timestamp":1768366794508,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T00:00:00Z","timestamp":1249344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s10557-009-6188-1","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T09:07:39Z","timestamp":1249290459000},"page":"395-401","source":"Crossref","is-referenced-by-count":22,"title":["Fibrates may Cause an Abnormal Urinary Betaine Loss Which is Associated with Elevations in Plasma Homocysteine"],"prefix":"10.1007","volume":"23","author":[{"given":"Michael","family":"Lever","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Slow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane L.","family":"Elmslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell S.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John N.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen T.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"6188_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0009-8981(94)90090-6","volume":"230","author":"M Lever","year":"1994","unstructured":"Lever M, Sizeland PC, Bason LM, Hayman CM, Robson RA, Chambers ST. Abnormal glycine betaine content of the blood and urine of diabetic and renal patients. Clin Chim Acta. 1994;230:69\u201379.","journal-title":"Clin Chim Acta"},{"key":"6188_CR2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0168-8227(98)00115-6","volume":"43","author":"WJ Dellow","year":"1999","unstructured":"Dellow WJ, Chambers ST, Lever M, Lunt H, Robson RA. Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia. Diab Res Clin Pract. 1999;43:91\u20139.","journal-title":"Diab Res Clin Pract"},{"key":"6188_CR3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clinbiochem.2003.11.004","volume":"37","author":"M Lever","year":"2004","unstructured":"Lever M, Sizeland PC, Frampton CM, Chambers ST. Short and long-term variation of plasma glycine betaine concentrations in humans. Clin Biochem. 2004;37:184\u201390.","journal-title":"Clin Biochem"},{"key":"6188_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2004.07.007","volume":"54","author":"M Lever","year":"2005","unstructured":"Lever M, George PM, Dellow WJ, Scott RS, Chambers ST. Homocysteine, glycine betaine, and N, N-dimethylglycine in patients attending a lipid clinic. Metabolism. 2005;54:1\u201314.","journal-title":"Metabolism"},{"key":"6188_CR5","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/ndt\/15.12.1993","volume":"15","author":"N Broeders","year":"2000","unstructured":"Broeders N, Knoop C, Antoine M, Tielemans AD. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent? Nephrol Dial Transplant. 2000;15:1993\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"6188_CR6","first-page":"39","volume":"55","author":"J Lipscombe","year":"2001","unstructured":"Lipscombe J, Lewis GF, Cattran D, Bargman JM. Deterioration in renal function associated with fibrate therapy. Clin Nephrol. 2001;55:39\u201344.","journal-title":"Clin Nephrol"},{"key":"6188_CR7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinbiochem.2006.11.010","volume":"40","author":"Y-H Lin","year":"2007","unstructured":"Lin Y-H, Pao K-Y, Wu V-C, Lin Y-L, Chien Y-F, Hung C-S, et al. The influence of estimated creatinine clearance on plasma homocysteine in hypertensive patients with normal serum creatinine. Clin Biochem. 2007;40:230\u20134.","journal-title":"Clin Biochem"},{"key":"6188_CR8","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/j.amjcard.2006.11.016","volume":"99","author":"MH Davidson","year":"2007","unstructured":"Davidson MH, Armani A, McKenney JM, Jacobson TA. Safety considerations with fibrate therapy. Am J Cardiol. 2007;99:3C\u201318C.","journal-title":"Am J Cardiol"},{"key":"6188_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11883-008-0005-3","volume":"10","author":"EA Brinton","year":"2008","unstructured":"Brinton EA. Does the addition of fibrates to statin therapy have a favorable risk to benefit ratio? Curr Atheroscler Rep. 2008;10:25\u201332.","journal-title":"Curr Atheroscler Rep"},{"key":"6188_CR10","first-page":"41","volume":"20","author":"C Hottelart","year":"1999","unstructured":"Hottelart C, El Esper N, Archard JM, Pruna A, Fournier A. Fenofibrate increases blood creatinine, but dies not change the glomerular filtration rate in patients with mild renal insufficiency. Nephrologie. 1999;20:41\u20134.","journal-title":"Nephrologie"},{"key":"6188_CR11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1991.71.4.1081","volume":"71","author":"A Garcia-Perez","year":"1991","unstructured":"Garcia-Perez A, Burg MB. Renal medullary organic osmolytes. Physiol Rev. 1991;71:1081\u2013115.","journal-title":"Physiol Rev"},{"key":"6188_CR12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1515\/BC.2002.059","volume":"383","author":"F Schliess","year":"2002","unstructured":"Schliess F, H\u00e4ussinger D. The cellular hydration state: a critical determinant for cell death and survival. Biol Chem. 2002;383:577\u201383.","journal-title":"Biol Chem"},{"key":"6188_CR13","unstructured":"Slow S, Lever M, Chambers ST, George PM. Plasma dependent and independent accumulation of betaine in male and female rat tissues. Physiol Res in press (available on-line as pre-press article 1569)."},{"key":"6188_CR14","unstructured":"Storer MK. Development of laboratory tests for assessing vitamin status. PhD Thesis, University of Otago, Dunedin, New Zealand 2006."},{"key":"6188_CR15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","volume":"345","author":"JA Lemos De","year":"2001","unstructured":"De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptides in patients with acute coronary syndromes. New Engl J Med. 2001;345:1014\u201321.","journal-title":"New Engl J Med"},{"key":"6188_CR16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-4165(94)90165-1","volume":"1200","author":"M Lever","year":"1994","unstructured":"Lever M, Sizeland PC, Bason LM, Hayman CM, Chambers ST. Glycine betaine and proline betaine in human blood and urine. Biochim Biophys Acta. 1994;1200:259\u201364.","journal-title":"Biochim Biophys Acta"},{"key":"6188_CR17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.clinbiochem.2009.02.001","volume":"42","author":"M Lever","year":"2009","unstructured":"Lever M, Atkinson W, Slow S, Chambers ST, George PM. Plasma and urine betaine and dimethylglycine variation in healthy young male subjects. Clin Biochem. 2009;42:706\u201312.","journal-title":"Clin Biochem"},{"key":"6188_CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.aca.2005.10.060","volume":"558","author":"MK Storer","year":"2006","unstructured":"Storer MK, Lever M. Aracyl triflates for preparing fluorescent and UV absorbing derivatives of unreactive carboxylates, amines and other metabolites. Anal Chim Acta. 2006;558:319\u201325.","journal-title":"Anal Chim Acta"},{"key":"6188_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.chroma.2005.11.123","volume":"1104","author":"MK Storer","year":"2006","unstructured":"Storer MK, McEntyre CJ, Lever M. Separation of cationic aracyl derivatives of betaines and related compounds. J Chromatogr A. 2006;1104:263\u201371.","journal-title":"J Chromatogr A"},{"key":"6188_CR20","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.clinbiochem.2007.05.021","volume":"40","author":"M Lever","year":"2007","unstructured":"Lever M, Atkinson W, George PM, Chambers ST. Sex differences in the control of plasma concentrations and urinary excretion of glycine betaine in patients attending a lipid disorders clinic. Clin Biochem. 2007;40:1225\u201331.","journal-title":"Clin Biochem"},{"key":"6188_CR21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jn\/138.5.914","volume":"138","author":"SV Konstantinova","year":"2008","unstructured":"Konstantinova SV, Tell GS, Vollset SE, Nyg\u00e5rd O, Bleie \u00d8, Ueland PM. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr. 2008;138:914\u201320.","journal-title":"J Nutr"},{"key":"6188_CR22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1159\/000064083","volume":"92","author":"C Hottelart","year":"2002","unstructured":"Hottelart C, El Esper N, Rose F, Achard JM, Fournier A. Fenofibrate increases creatininemia by increasing metabolic production of creatinine. Nephron. 2002;92:536\u201341.","journal-title":"Nephron"},{"key":"6188_CR23","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","volume":"366","author":"The FIELD study investigators","year":"2005","unstructured":"The FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366:1849\u201361.","journal-title":"Lancet"},{"key":"6188_CR24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.ajkd.2004.11.004","volume":"45","author":"JC Ansquer","year":"2005","unstructured":"Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G. Fenofibrate reduces progression to microalbuminuria over 3\u00a0years in a placebo controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS). Am J Kidney Dis. 2005;45:485\u201393.","journal-title":"Am J Kidney Dis"},{"key":"6188_CR25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.clinbiochem.2007.03.009","volume":"40","author":"M Lever","year":"2007","unstructured":"Lever M, Atkinson W, Chambers ST, George PM. An abnormal urinary excretion of glycine betaine may persist for years. Clin Biochem. 2007;40:798\u2013801.","journal-title":"Clin Biochem"},{"key":"6188_CR26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00041433-199912000-00011","volume":"10","author":"GF Watts","year":"1999","unstructured":"Watts GF, Dimmitt SB. Fibrates, dyslipoproteinaemia and cardiovascular disease. Curr Opin Lipidol. 1999;10:561\u201374.","journal-title":"Curr Opin Lipidol"},{"key":"6188_CR27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/ATVBAHA.107.148817","volume":"28","author":"PJ Barter","year":"2008","unstructured":"Barter PJ, Rye K-A. Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? Arterioscler Thromb Vasc Biol. 2008;28:39\u201346.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6188_CR28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.bbrc.2006.09.099","volume":"350","author":"S Luci","year":"2006","unstructured":"Luci S, Geissler S, K\u00f6nig B, Koch A, Stangl GI, Hirche F, et al. PPAR-\u03b1 agonists up-regulate organic cation transporters in rat liver cells. Biochem Biophys Res Comm. 2006;350:704\u20138.","journal-title":"Biochem Biophys Res Comm"},{"key":"6188_CR29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2008.01.008","volume":"583","author":"R Ringseis","year":"2008","unstructured":"Ringseis R, Luci S, Spielmann J, Kluge H, Fischer M, Geissler S, et al. Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species. Eur J Pharmacol. 2008;583:11\u20137.","journal-title":"Eur J Pharmacol"},{"key":"6188_CR30","doi-asserted-by":"crossref","first-page":"F584","DOI":"10.1152\/ajprenal.2000.279.3.F584","volume":"279","author":"CA Wagner","year":"2000","unstructured":"Wagner CA, L\u00fckewille U, Kaltenbach S, Moschen I, Br\u00f6er A, Risler T, et al. Functional and pharmacological characterization of human Na+-carnitine cotransporter hOCTN2. Am J Physiol Renal Physiol. 2000;279:F584\u201391.","journal-title":"Am J Physiol Renal Physiol"},{"key":"6188_CR31","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1093\/jn\/133.12.4135","volume":"133","author":"MR Olthof","year":"2003","unstructured":"Olthof MR, van Vliet T, Boelsma E, Verhoef P. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr. 2003;133:4135\u20138.","journal-title":"J Nutr"},{"key":"6188_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jn\/136.1.34","volume":"136","author":"U Schwab","year":"2006","unstructured":"Schwab U, Torronen A, Meririnne E, Saarinen M, Alfthan G, Aro A, et al. Orally administered betaine has an acute and dose-dependent effect on serum betaine and plasma homocysteine concentrations in healthy humans. J Nutr. 2006;136:34\u20138.","journal-title":"J Nutr"},{"key":"6188_CR33","doi-asserted-by":"crossref","unstructured":"Taskinen M-R, Sullivan DR, Ehnholm C, Whiting M, Zannino D, Simes RJ, Keech AC, Barter PJ Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate. Arterioscler Thromb Vasc Biol. 2009;29.","DOI":"10.1161\/ATVBAHA.108.178228"},{"key":"6188_CR34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/ajcn\/87.3.577","volume":"87","author":"W Atkinson","year":"2008","unstructured":"Atkinson W, Elmslie J, Lever M, Chambers ST, George PM. Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and post methionine load conditions in healthy male subjects. Am J Clin Nutr. 2008;87:577\u201385.","journal-title":"Am J Clin Nutr"},{"key":"6188_CR35","doi-asserted-by":"crossref","unstructured":"Atkinson A, Slow S, Elmslie J, Lever M, Chambers ST, George PM. Dietary and supplementary betaine: effects on betaine and homocysteine concentrations in males. Nutr Metab Cardiovasc Dis. 2009.","DOI":"10.1016\/j.numecd.2009.01.004"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-009-6188-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-009-6188-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-009-6188-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:28:05Z","timestamp":1559237285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-009-6188-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,4]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["6188"],"URL":"https:\/\/doi.org\/10.1007\/s10557-009-6188-1","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,4]]}}}